BRIEF published on 11/17/2025 at 18:28, 7 months 12 days ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Form 8.3 The Vanguard Group Takeover Code Financial Disclosure Bluefield Solar
BRIEF published on 11/17/2025 at 18:28, 7 months 12 days ago Le groupe Vanguard révèle sa participation dans le fonds Bluefield Solar Income. Code De Prise De Contrôle Divulgation Financière Le Groupe Vanguard Formulaire 8.3 Bluefield Solar
PRESS RELEASE published on 11/17/2025 at 18:27, 7 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% interest in JTC plc with Form 8.3 submission. Disclosure includes positions and dealings in relevant securities Securities Form 8.3 Disclosure The Vanguard Group JTC Plc
BRIEF published on 11/17/2025 at 18:26, 7 months 12 days ago The Vanguard Group Discloses Position in Spire Healthcare Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
BRIEF published on 11/17/2025 at 18:26, 7 months 12 days ago Le groupe Vanguard révèle sa participation dans Spire Healthcare Spire Healthcare Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Informations Sur Les Valeurs Mobilières
PRESS RELEASE published on 11/17/2025 at 18:25, 7 months 12 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.67% ownership of Avadel Pharmaceuticals plc in Form 8.3 submitted to the Irish Takeover Panel The Vanguard Group, Inc. Form 8.3 Disclosure Ownership Avadel Pharmaceuticals Plc
BRIEF published on 11/17/2025 at 18:25, 7 months 12 days ago Vanguard Group's Disclosure on Alphawave IP Group Form 8.3 Takeover Code Securities Disclosure Vanguard Group Alphawave IP
BRIEF published on 11/17/2025 at 18:25, 7 months 12 days ago Divulgation du groupe Vanguard concernant Alphawave IP Group Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Alphawave IP
BRIEF published on 11/17/2025 at 18:24, 7 months 12 days ago The Vanguard Group's Disclosure on Dowlais Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Dowlais Group
BRIEF published on 11/17/2025 at 18:24, 7 months 12 days ago Information communiquée par le groupe Vanguard sur Dowlais Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Groupe Dowlais
Published on 06/30/2026 at 12:30, 1 minute ago iFabric Announces 2026 Annual General Meeting Voting Results
Published on 06/30/2026 at 09:01, 3 hours 30 minutes ago Apex Mobilizes Drill Rig and Commences 2026 Exploration Program at the Cap Critical Minerals Project
Published on 06/30/2026 at 08:05, 4 hours 26 minutes ago Notice of Annual and Special Meeting of Shareholders
Published on 06/30/2026 at 11:37, 54 minutes ago Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
Published on 06/30/2026 at 11:15, 1 hour 16 minutes ago Greenworks renforce sa localisation en Europe et fait de l’outillage électrique un pilier de sa stratégie mondiale
Published on 06/30/2026 at 11:15, 1 hour 16 minutes ago Greenworks Deepens Its Localisation Strategy in Europe, Building a New Pillar for Global Growth
Published on 06/30/2026 at 11:05, 1 hour 26 minutes ago Rockwell Automation Announces German-Language Season of ROKStudios Featuring OEM Lifecycle Perspectives
Published on 06/30/2026 at 07:30, 5 hours 1 minute ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:30, 5 hours 1 minute ago Gimv cède sa participation dans AlpenBlu Clinics (précédemment Les Psy Réunis), acteur suisse des soins ambulatoires en santé mentale, à Impact Healthcare
Published on 06/30/2026 at 07:00, 5 hours 31 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
